Kein Unternehmensprofil gefunden.
Aktuelle News
News Funktionen
Weitere Funktionen
3 April 2017
12:30
Corporate
EN
Sucampo Pharmaceuticals, Inc.
Corporate
EN
Sucampo Acquires Vtesse Inc.
13 März 2014
01:00
Corporate
EN
Sucampo Pharmaceuticals, Inc.
Corporate
EN
Sucampo Receives Notice that Second Indication for AMITIZA for Opioid-Induced Constipation Is Not Approved by Medicines and Healthcare Products Regulatory Agency in U.K.
01:00
Corporate
EN
Sucampo Pharmaceuticals, Inc.
Corporate
EN
Sucampo Receives Notice that Second Indication for AMITIZA for Opioid-Induced Constipation Is Not Approved by Medicines and Healthcare Products Regulatory Agency in U.K.
10 Februar 2014
22:02
Corporate
EN
Sucampo Pharmaceuticals, Inc.
Corporate
EN
Sucampo Names Peter Greenleaf Chief Executive Officer
22:02
Corporate
EN
Sucampo Pharmaceuticals, Inc.
Corporate
EN
Sucampo Names Peter Greenleaf Chief Executive Officer
22 Oktober 2013
02:00
Corporate
EN
Sucampo Pharmaceuticals, Inc.
Corporate
EN
Sucampo Announces Completion of Patient Enrollment in a Phase 3 Clinical Study of Unoprostone Isopropyl for Retinitis Pigmentosa
Kursinformation
Für dieses Unternehmen ist kein Kurs-Chart verfügbar.
()